Editorial
Welcome to the first homepage edition of i2P for 2012.
In many ways it has been a slow start to the New Year because of having to deal with the “leftovers” from 2011.
One of those items for i2P was that a third-party provider to the site did not advise of a code change to the security section in our subscribe panel, creating a range of frustrated subscribers not able to get on board.
We apologise to all those potential subscribers who were unable to register with us in the second half of 2011, but if you try once more you should have no problem.
Columns
Rollo Manning: Pharma-Goss
Linda Bryant: Inside NZ
Loretta Marron BSc: Health Watch
Barry Urquhart: Marketing Focus
Mark Neuenschwander: I`ve been thinking about...Recent Comments
Past Editions
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 2012 Number 1
Health Politics
Neil Johnston: Friends of Science in Medicine
Peter Sayers: Confessions of a Frustrated Pharmacist
James Ellerson: $75.5 million in 5CPA lying idle. Why is it so?EPublications
QUMAX –where to from here?
Printer-friendly version
Send to friend
PDF version | Karalyn Huxhagen |
Karalyn Huxhagen is the manager of a large Friendly Society pharmacy in Mackay, Queensland and is active in all facets of pharmacy (including the cause of women in pharmacy). A natural leader and a very busy mother of two girls she still finds time to be a Queensland PSA councilor, and sits on many committees involved in pharmacy issues. | |
In April 2010 the current program for QUMAX (Quality use of medicine in aboriginal community controlled centres) will come to an end.
This was a pilot program and work is being done to look at where to from here?
Like all pilots the program took some time to achieve its goals but achieve them it did.
The evaluation process has been ongoing and the feedback from pharmacists and patients has been excellent.
There are some problems with the current format. What I need from everyone is feedback on what you liked, what you hated, what we missed in the pilot and any other wonderful ideas you may have to build on this program. You can email these to me at karalynh@bigpond.net.au . If you would like to discuss any of your ideas I am happy to do so. Just send me an email and then will establish a time for a chat.
While I cannot promise or discuss what the current program will evolve into I do need to ensure that I know what format community pharmacists would like to see the program grow into.
One of the success stories of the program has been the increase in adherence and compliance since the PBS copayment and the Dosage administration aids have been provided free of charge. This has made a phenomenal difference for those of us who have been working with these issues for so many years.
The other area that has received quite a lot of attention is the provision of patient medication profiles and Home Medicine reviews to the Aboriginal and Torres Strait islander clients. Reaching these clients in the HMR program has never met the targets that are needed
The current model of HMR does not work for these people. Alternatives need to be explored and the evaluation work from QUMAX and that of Campbell Research into the HMR program needs to be heeded and utilized. I am heartened to see that PPSAC (Professional Programs and services advisory committee) will be looking at this research and the recommendations that were developed. The provision of HMR’s in rural and remote Australia and to the Aboriginal and Torres Strait Islander people does need models with more flexibility and hopefully PPSAC can develop a strategy to ensure that alternative models are available.
So please do send me any comments, ideas etc that you have about the QUMAX program. karalynh@bigpond.net.au
Research Reports
Dr Andrew Byrne & Associates: Tranquillizer use rife amongst OTP subjects world-wide, most legally prescribedPractice Development
Neil Retallick: Are the discounters impacting community pharmacy beyond margin erosion? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Support services for pharmacists and doctors in the United Kingdom – Part 3 Royal Medical Benevolent Fund | open full screen
Staff Writer: Catch the early wave in 2012 and secure your valuable CPD Credits at the Guild Pharmacy Academy – NSW Convention | open full screen
Information Technology
Dr David More: Australian Health Information Technology LinksIndigenous Health
Preventive Medicine
Gerald Quigley: It’s Time!If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
Submitted by Dr Pauline Vunipola on Thu, 01/10/2009 - 01:01.
totally agree with the difference this qumax does. the adherence and compliance is great. we are collecting data pre and post qumax and we are getting good numbers of achieving BP targets, Lipid LDL targets, HbA1c and improving microalbuminuria as a result of qumax and dose administration aids.by using a criteria in which we required the return of patients for review 3monthly in order for their qumax scripts to continue, their care and treatment are better revised and target achieved... This is the best direct assistance to aboriginal patients thats ever happened in recent times, I reckon..
Post new comment